SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-11-001010
Filing Date
2011-08-26
Accepted
2011-08-26 14:45:25
Documents
7
Period of Report
2011-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 19809
2 NEWS RELEASE DATED JUNE 21, 2011 ex991.htm EX-99.1 15960
3 NEWS RELEASE DATED JULY 22, 2011 ex992.htm EX-99.2 17509
4 NEWS RELEASE DATED AUGUST 8, 2011 ex993.htm EX-9.3 11156
5 NEWS RELEASE DATED AUGUST 15, 2011 ex994.htm EX-99.4 16104
6 NEWS RELEASE DATED AUGUST 26, 2011 ex995.htm EX-99.5 92245
7 LOGO loruslogo.jpg GRAPHIC 11681
  Complete submission text file 0001279569-11-001010.txt   190237
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 111059510
SIC: 2836 Biological Products, (No Diagnostic Substances)